Credit: Pietro Jeng from Pexels
A class of diabetes medications, that include the very popular drug Ozempic, are related to a lowered danger of particular obesity-related cancers, according to a research study launched Friday.
Released in the journal JAMAthe research study compared clients with Type 2 diabetes who were treated with insulin versus clients who were provided a class of drug called GLP-1 agonists, like Ozempic, in between 2005 and 2018.
The scientists discovered that the clients who got GLP-1 agonists had a substantially lower danger of establishing 10 out of 13 cancers studied, consisting of kidney, pancreatic, esophageal, ovarian, liver and colorectal cancer.
Amongst the cancers which saw no substantial modification in danger were thyroid cancer and breast cancer in postmenopausal ladies.
“Obesity is popular to be connected with a minimum of 13 cancer types,” research study author Rong Xu stated in an e-mail to AFP.
“Our research study supplies proof that GLP-1RAs hold guarantee in breaking the link in between weight problems and cancer,” Xu stated.
Amongst the drugs studied were semaglutide– commercially offered as Ozempic– in addition to liraglutide and others. Ozempic was authorized in the United States in 2017.
GLP-1 agonists have actually been around for about 20 years, however a brand-new generation of these drugs, amongst them Ozempic, has actually been promoted for their more substantial weight-loss impacts.
Xu recommended that the protective advantages showed in the research study might motivate physicians to recommend GLP-1 treatments for diabetes clients rather of other medications like insulin.
More info: Lindsey Wang et al, Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes, JAMA Network Open (2024 ). DOI: 10.1001/ jamanetworkopen.2024.21305
© 2024 AFP
Citation: Diabetes drugs like Ozempic lower cancer threats: Study (2024, July 6) obtained 11 September 2024 from https://medicalxpress.com/news/2024-07-diabetes-drugs-ozempic-cancer.html
This file goes through copyright. Apart from any reasonable dealing for the function of personal research study or research study, no part might be replicated without the composed consent. The material is attended to info functions just.
